Prof Anthony Gordon is the Head of Division of Anaesthetics, Pain Medicine and Intensive Care at Imperial, and NIHR Senior Investigator. His research focuses on developing precision medicine in sepsis.

He leads a multidisciplinary group investigating the use of -omic techniques and artificial intelligence (AI) to improve outcomes in sepsis. He has led multiple clinical trials that have shaped international sepsis guidelines. He leads the REMAP-CAP trial for COVID-19 and influenza in the UK, that has improved treatments for and saved hundreds of thousands of lives from severe COVID-19 around the world. He is the Director of the NIHR/NHS National Collaboration Research Programme (NRCP).

Catherine Nelson-Piercy is a Consultant Obstetric Physician at Guy’s and St. Thomas’ Hospitals Trust and the Lead Obstetric Physician for the South East London Maternal Medicine Network. In 2010 she was awarded the title of Professor of Obstetric Medicine at King’s College London. Her undergraduate studies were at King’s College, Cambridge University and St Bartholomew’s Hospital. She trained as a physician, and was taught Obstetric Medicine by Professor Michael de Swiet.

Professor Nelson-Piercy is past President of the International Society of Obstetric Medicine (ISOM). She was founding co-editor in chief of the journal ‘Obstetric Medicine: the medicine of pregnancy.’

Professor Nelson-Piercy is a member of the NHS England expert group that developed the Networked model for maternal medicine and has been involved in the development of several evidence-based National Guidelines notably the RCOG Green top guidelines on “Reducing the risk of thromboembolism during pregnancy, birth & the puerperium” and ‘Management of nausea vomiting of pregnancy and hyperemesis gravidarum”. She has over 280 publications and has edited five books and written the successful Handbook of Obstetric Medicine, now in its sixth edition. She is also one of the central physician assessors for the UK Confidential Enquiries into Maternal Deaths. 

Professor Colin Melville has significant experience and expertise as a senior medical educationalist and NHS leader with previous roles encompassing Clinical Director, Medical Director, Director of Medical Education and Foundation School Director. He went on to senior academic leadership positions at HYMS, Warwick and Lancaster medical schools before joining the GMC as Medical Director and Director of Education and Standards in 2017.

As a member of the executive, he has led significant developments to the work of the GMC in support of undergraduate and postgraduate medical education, and in the key professional standards, Good medical practice.

He is currently leading on innovations and changes to medical training to meet public and service need, and support a culture of compassionate leadership.
His contributions have been recognised with Honorary Fellowship of the Academy of Medical Educators, Honorary Professor of Medical Education at the University of Manchester and Visiting Professor at Anglia Ruskin University.

Danny is a Consultant in adult Intensive Care Medicine in Sheffield. In October 2022 she became FICM Dean, and embarked on leading the Faculty in work to form a  UK College of ICM. Danny’s other previous professional roles have included working on FICM Board as Lead Regional Advisor and Chair of the Careers, Recruitment and Workforce committee. Other roles have included a secondment to NHS Resolution advising on medical performance issues, an Associate Postgraduate Dean and National Critical Care Tutor for the Royal College of Surgeons of England.

Her clinical and research interests are focused on decision making and frailty assessment in critical care. Danny also has undergraduate and postgraduate degrees in law which have led to her medical professional interests in the wider area of medical professionalism and medical leadership.

She is proud to be a committed trainer and educational supervisor for intensivists in training.

Luigi Camporota is the Past Chair of the Acute Respiratory Failure Section of the European Society of Intensive Care Medicine (ESICM) and on the Editorial Board of the American Journal of respiratory and Critical Care Medicine (AJRCCM) and Intensive Care Medicine (ICM). His clinical and research interest is His clinical and research interest in Respiratory failure, ARDS, mechanical ventilation, respiratory monitoring, extracorporeal membrane oxygenation (ECMO) and extracorporeal carbon dioxide removal (ECCO2R). He has contributed to over 260 published peer-reviewed papers and > 20 book chapters and edited a book in Intensive Care.

Charlotte graduated in both Biomedical Sciences and Medicine from the University of Southampton, and later undertook a Wellcome Trust-funded PhD at the University of Cambridge, alongside specialist clinical training in Respiratory (Cambridge) and Intensive Care Medicine (London). Subsequently, Charlotte was appointed as the UK’s first National Institute of Health Research (NIHR) Clinical Lecturer in Intensive Care Medicine, and awarded both a Fulbright All-Disciplines Scholar Award and a Wellcome Trust Fellowship for Postdoctoral Clinician Scientists to undertake research at the University of California, San Francisco.  Charlotte returned to Cambridge in 2015, where she established a research group focusing on understanding the mechanisms underlying pneumonia, its more severe form, acute respiratory distress syndrome, and the translation of those insights into therapeutic benefits for patients.

Charlotte made a significant contribution to the global COVID response, advising the UK, German, US and other governments in her areas of expertise. As a member of the UK-COVID Therapeutic Advisory Panel, she was one of the team prioritising the therapies that should be investigated in the UK’s nine COVID platform clinical trials (including RECOVERY and REMAP-CAP), and she now undertakes a similar role for the national influenza clinical trial. Charlotte is the Chief Investigator of HEAL-COVID, a platform clinical trial open at 110 hospital sites across all four nations of the UK that aims to find drug therapies to improve the longer-term clinical outcomes of people who were hospitalised with COVID-19.